Gene · 3802
Papers2,190
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,190
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combination of Expanded Allogeneic NK Cells and T Cell-Based Immunotherapy Exert Enhanced Antitumor Effects. | Cancers (Basel) | 2022 | 36612246 | PubTator, text mining | PubMed |
| Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer. | Front Immunol | 2022 | 36601109 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma. | Front Oncol | 2022 | 36591519 | PubTator, text mining | PubMed |
| Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell immunoprofiling. | Front Immunol | 2022 | 36591270 | PubTator, text mining | PubMed |
| Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease. | Front Immunol | 2022 | 36569951 | PubTator, text mining | PubMed |
| Relevant biomarkers of kidney allograft rejection. | J Med Life | 2022 | 36567832 | PubTator, text mining | PubMed |
| Immune Profile of Blood, Tissue and Peritoneal Fluid: A Comparative Study in High Grade Serous Epithelial Ovarian Cancer Patients at Interval Debulking Surgery. | Vaccines (Basel) | 2022 | 36560531 | PubTator, text mining | PubMed |
| Harnessing NK Cells to Control Metastasis. | Vaccines (Basel) | 2022 | 36560427 | PubTator, text mining | PubMed |
| Distribution of KIR Genes and Their HLA Ligands in Different Viral Infectious Diseases: Frequency Study in Sicilian Population. | Int J Mol Sci | 2022 | 36555106 | PubTator, text mining | PubMed |
| Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma. | Front Immunol | 2022 | 36544782 | PubTator, text mining | PubMed |
| IRF2 is required for development and functional maturation of human NK cells. | Front Immunol | 2022 | 36544762 | PubTator, text mining | PubMed |
| CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire. | Front Immunol | 2022 | 36531994 | PubTator, text mining | PubMed |
| The roles and clinical applications of interleukins in endometrial carcinoma. | Front Oncol | 2022 | 36531027 | PubTator, text mining | PubMed |
| Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells. | Acta Neuropathol Commun | 2022 | 36527106 | PubTator, text mining | PubMed |
| Generation and functional characterization of a multigene-modified NK101 cell line exerting diverse mechanisms of antitumor action. | Oncoimmunology | 2022 | 36524207 | PubTator, text mining | PubMed |
| Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma. | Front Med (Lausanne) | 2022 | 36507493 | PubTator, text mining | PubMed |
| Roles of platelets in tumor invasion and metastasis: A review. | Heliyon | 2022 | 36506354 | PubTator, text mining | PubMed |
| Single-cell transcriptomics in bone marrow delineates CD56dimGranzymeK+ subset as intermediate stage in NK cell differentiation. | Front Immunol | 2022 | 36505452 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of PB and BM NK cells from severe aplastic anaemia patients. | Clin Transl Med | 2022 | 36471484 | PubTator, text mining | PubMed |
| Benchmarking challenging small variants with linked and long reads. | Cell Genom | 2022 | 36452119 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3802/papers?page=14